Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Sodium-Potassium ATPase (Na+/K+ ATPase) is a transmembrane protein responsible for maintaining electrochemical gradients by actively transporting three sodium ions out of the cell and two potassium ions into the cell for each ATP molecule hydrolyzed. It is crucial for maintaining resting membrane potential, regulating cell volume, and enabling secondary active transport processes. It is a therapeutic target for cardiac glycosides used in treating congestive heart failure and arrhythmias.
Inhibition of Na+/K+ ATPase activity, leading to increased intracellular calcium.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-Potassium Adenosine Triphosphatase (Na+/K+ ATPase).